ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

Bevacizumab Prolongs Survival In Patients With Advanced Colorectal Cancer

November 26, 2004

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

November 28, 2014

In Brief: Eight Minority CCP Awards Confirmed, Four More Coming; General Motors Winners Named

June 15, 1990

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

Mammography Debate “Confused a Whole Generation” – Shalala

January 7, 1994

ONS Award Winners, Grantees, Announced At Annual Congress

July 27, 1990